Mirvat Alasnag/X
Sep 2, 2025, 08:14
Mirvat Alasnag Discusses OPTION-STEMI Findings Published in The Lancet
Mirvat Alasnag posted on X:
”OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease via PCRonline.
Presented – ESC Congress
Published simultaneously – The Lancet.”
Read the full report here.
More recent insights on Hemostasis Today.
Antonia Lukito
Antonio Sorropago
Anuradha Tunuguntla
Atul Mathur
ESC
ESC 2025
ESC Congress
European Society of Cardiology
Hady Lichaa
Hematology
Hemostasis
Hemostasis Today
Kasper Kyhl
Luis Ortega-Paz
Marwan Saad
Mirvat Alasnag
Multivessel disease
OPTION-STEMI
Revascularisation
Ronnie Lassiaille
Salvatore Brugaletta
Sarah Fairley
Sarita Rao
ST-elevation myocardial infarction
STEMI
thrombosis
-
Jun 4, 2026, 05:42Subramamyam Penubaku: Early Recognition and Risk-Based Management of Acute Pulmonary Embolism
-
Jun 4, 2026, 05:30Raghavendra Rao: Early Endothermal Ablation and Contemporary Management of Superficial Venous Thrombosis
-
Jun 4, 2026, 05:18Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity